Natural products from the hallucinogenic sage

Science Progress

Volumn 93, Issue 2, 2010, Pages 171-180

  Hanson, James R ^a  

^a NONE

Author keywords

Clerodanes; Diterpenoids; Opioid receptors; Salvia divinorum; Salviarins

Indexed keywords

EID: 77954055552     PISSN: 00368504     EISSN: None     Source Type: Journal    
DOI: 10.3184/003685010X12626983776947     Document Type: Article

References (44)

1. Grieve, M. (1931) Leyel, C.F. (ed.) A modern herbal, pp. 700-707. Penguin Books, 1976, Harmondsworth.
2. Usher, G. (1974) A dictionary of plants used by man, p. 520-521, Constable, London.
3. Ulubelen, A. (2003) Cardioactive and anti-bacterial terpenoids from some Salvia species. Phytochemistry, 64, 395-399.
4. Roth, B.L., Baner, K., Westkaemper, R., Siebert, D., Rice, K.C., Steinberg, S., Ernsberger, P. and Rothman, P.B. (2002) Salvinorin A, A potent naturally occurring non-nitrogenous k-opioid receptor agonist. Proc. Natl. Acad. Sci., USA, 99, 11934-11939.
5. Emboden, W. (1979) Narcotic plants, pp. 93-95, Cassell, London.
6. Ortega, A., Blount, J.F. and Manchand, P.S. (1982) Salvinorin, A new trans neoclerodane diterpene from Salvia divinorum. J. Chem. Soc., Perkin Trans. 1, 2505-2508.
7. Koreeda, M., Brown, L. and Valdes, L.J. (1990) The absolute stereochemistry of the salvinorins. Chem. Lett., 2015-2018.
8. Valdes, L.J., Bitler, W.M., Hatfield, G.M., Paul, A.G. and Koreeda, M. (1984) Divinorin A, a psychotropic terpenoid and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum. J. Org. Chem., 49, 4716-4720.
9. Merritt, A.T. and Ley, S.V. (1992) Clerodane diterpenoids, Nat. Prod. Rep., 9, 243-287.
10. Barton, D.H.R. and Elad, D. (1956) Columbo root bitter principles part II, The constitution of columbin. J. Chem. Soc., 2090-2095.
11. Sim, G.A., Hamor, T.A., Paul, I.C. and Robertson, J.M. (1961) The structure of clerodin. Proc. Chem. Soc., 75-76.
12. Barton, D.H.R., Cheung, H.T., Cross, A.D., Jackman, L.M. and Martin-Smith, M. (1961), Diterpenoid bitter principles, part III, The constitution of clerodin. J. Chem. Soc., 5061-5073.
13. Rogers, D., Unal, G.G., Williams, D.J., Ley, S.J., Joshi, B.S. and Ravindranath, K.R. (1979), The crystal structure of 3-epicaryopterin and the reversal of the currently accepted absolute configuration of clerodin. J. C. S. Chem. Commun., 97-99.
14. Martinez-Ripoli, M., Fayos, J., Rodriguez, B., Garcia-Alvarez, M.C., Savona, G., Piozzi, F., Paternostro, M.P. and Hanson, J.R. (1981) The absolute stereochemistry of some clerodane diterpenoids from Teucrium species. J. Chem. Soc., Perkin Trans. 1, 1186-1190.
15. Brieskorn, C. and Stehle, T. (1973) Labiate bitter principles, A new compound of the clerodane type. Chem. Ber., 106, 922-924.
16. Savona, G., Paternostro, M.P., Piozzi, F., Hanson, J.R., Hitchcock, P.B. and Thomas, S.A. (1978) Salviarin, A new diterpenoid from Salvia splendens. J. Chem. Soc., Perkin Trans. 1, 643-646.
17. Savona, G., Paternostro, M.P., Piozzi, F. and Hanson, J.R. (1979) Splendidin, a new trans clerodane from Salvia splendens. J. Chem. Soc., Perkin Trans. 1, 533-534.
18. Shirota, 0., Nagamatsu, K. and Sekita, S. (2006) Neoclerodane diterpenes from the hallucinogenic sage, Salvia divinorum. J. Nat. Prod., 69, 1782-1786.
19. Valdes, L.J., Chang, H.M., Visger, D.C. and Koreeda, M. (2001) Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint. Salvia divinorum. Org. Lett., 3, 3935-3937.
20. Munro, T.A. and Rizzacasa, M.A. (2003) Salvinorins D-F, New neoclerodane diterpenoids from Salvia divinorum and an improved method for the isolation of salvinorin A. J. Nat. Prod., 66, 703-705.
21. Bigham, A.K., Munro, T.A., Rizzacasa, M.A. and Robins-Browne, R.M. (2003) Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage, Salvia divinorum. J. Nat. Prod., 66, 1242-1244.
22. Lee, D.Y.W., Ma, Z., Liu-Chen, L.Y., Wang, Y., Chen. Y., Carlezon, W.A. and Cohen, B. (2005), New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human k-opioid receptors. Bioorg. Med. Chem., 13, 5635-5639.
23. Harding, W.W., Tidgewell, K., Schmidt, M., Shah, K., Dersch, C.M., Snyder, J., Parrish, D., Deschamps, J.R., Rothman, R.B. and Prisinzano, T.E. (2005) Salvinicins A and B, New neoclerodane diterpenes from Salvia divinorum. Org. Lett., 7, 3017-3020.
24. Greyer, R.J., Eckert, M.R., Veitch, N.C., Kite, G.C., Marin, P.D., Kokubun, T., Simmonds, M.S.J. and Paton, A.J. (2003) The chemotaxonomic significance of two bioactive caffeic acid esters, nepetoidins A and B in the Lamiaceae. Phytochemistry, 64, 519-528.
25. Valdes, L.J. (1986) Loliolide from Salvia divinorum. J. Nat. Prod., 49, 171.
26. Schmidt, M.S., Prisinzano, T.E., Tidgewell, K., Harding, W., Butelman, E.R., Kreek, M.J. and Murry, D.J. (2005), Determination of salvinorin A in body fluids by HPLC-atmospheric pressure C.I. J. Chromatog. B, 818, 221-225.
27. Prisinzano, T.E. and Rothman, R.B. (2008) Salvinorin A analogs as probes in opioid pharmacology. Chem. Rev., 108, 1732-1743.
28. Munro, T.A., Rizzacasa, M.A., Roth, B.L., Toth, B.A. and Yan, F. (2005), Studies towards the pharmacophore of Salvinorin A, A potent k-opioid receptor agonist. J. Med. Chem., 48, 345-348.
29. Harding, W.W., Tidgewell, K., Byrd, N., Cobb, H., Dersch, C.M., Butelman, E.R., Rothman, R.B. and Prisinzano, T.E. (2005) Neoclerodane diterpenes as a novel scaffold for m-opioid receptor ligands. J. Med. Chem., 48, 4765-4771.
30. Harding, W.W., Schmidt, M., Tidgewell, K., Kannan, P., Holden, K.G., Gilmour, B., Navarro, H., Rothman, R.B. and Prisinzano, T.E. (2006) Synthetic studies of neoclerodane diterpenes from Salvia divinorum, semi-synthesis of salvinicins A and B and other chemical transformations of salvinorin A. J. Nat. Prod., 69, 107-112.
31. Simpson, D.S., Katavic, P.L., Lozama, A., Harding, W.W., Parrish, D., Deschamps, J.R., Dersch, C.M., Partilla, J.S., Rothman, R.B., Navarro, H. and Prisinzano, T.E. (2007) Synthetic studies of neoclerodane diterpenes from Salvia divinorum, preparation and opioid receptor activity of salvinicin analogues. J. Med. Chem., 50, 3596-3603.
32. Munro, T.A., Goetchius, Roth, B.L., Vortherms, T.A. and Rizzacasa, M.A. (2005) Autoxidation of salvinorin A under basic conditions. J. Org. Chem., 70, 10057-10061
33. Ma, Z. and Lee, D.Y.W. (2007) Revised structure of deacetyl-1, 10-didehy drosalvinorin G. Tetrahedron Lett., 48, 5461-5464.
34. Munro, T.A., Duncan, K.K., Xu, W., Wang, Y., Liu-Chen, L.Y., Carlezon, W.A., Cohen, B.M. and Beguin, C. (2008) Standard protecting groups create potent and selective k-opioids, salvinorin B alkoxymethyl ethers. Bio-org. Med. Chem., 16, 1279-1286.
35. Beguin, C., Duncan, K.K., Munro, T.A., Ho, D.M., Xu, W., Liu-Chen, L.Y., Carleson, W.A. and Cohen, B. (2009) Modification of the furan ring of salvinorin A; identification of a selective partial agonist at the k-opioid receptor. Bio-org. Med. Chem., 17, 1370-1380.
36. Li, Y., Husbands, S.M., Mahon, M.F., Traynor, J.R. and Rowan, M.G. (2007) Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the k-opioid receptor. Chem. Biodivers., 4, 1586-1593.
37. Fontane G., Savona, G., Rodriguez, B., Dersch, C.M., Rothman, R.B. and Prisinzano, T.E. (2008) Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptor affinity. Tetrahedron, 64, 10041-10048.
38. Fontane, G., Savona, G., Rodriguez, B., Dersch, C.M., Rothman, R.B. and Prisinzano, T.E. (2009) Synthetic studies of neoclerodane diterpenoids from Salvia splendens:oxidative modifications of ring A. Tetrahedron, 65, 1708-1715.
39. Tidgewell, K., Harding, W.W., Schmidt, M., Holden, K.G., Murry, D.J. and Prisinzano, T.E. (2004) A facile method for the preparation of deuterium labelled salvinorin A. Bio-org. Med. Chem. Lett., 14, 5099-5102.
40. Yan, F., Mosier, P.D., Westkaemper, R.B., Stewart, J., Zjawiony, J.K., Vortherms, T.A., Scheffler, D.J. and Roth, B.L. (2005) Identification of the molecular mechanisms by which salvinorin A binds to k-opioid receptors. Biochemistry, 44, 8643-8651.
41. Kane, B.E., McCurdy, C.R. and Ferguson, D.M. (2008) Toward a structure based model of salvinorin A recognition of the k-opioid receptor. J. Med. Chem., 51, 1824-1830.
42. Scheerer, J.R., Lawrence, J.F., Wang, G.C. and Evans, D.A. (2007) Asymmetric synthesis of salvinorin A, a potent k-opioid receptor agonist. J. Am. Chem. Soc., 129,8969.
43. Nozawa, M., Suka, Y., Hoshi, T., Suzuki, T. and Hagiwara, H. (2008) Total synthesis of the hallucinogenic neoclerodane diterpernoid salvinorin A. Org. Lett., 10, 1365-1368.
44. Kutrzeba, L., Dayan, F., Howell, J.L., Feng, J., Giner, J.L. and Zjawiony, J.K. (2007) Biosynthesis of salvinorin A proceeds through the deoxyxylulose phosphate pathway. Phytochemistry, 68, 1872-1881.